Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Price (Quote)

$1.23
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $1.23 $1.23 Friday, 27th May 2022 CTRV stock ended at $1.23. During the day the stock fluctuated 0% from a day low at $1.23 to a day high of $1.23.
90 days $0.94 $1.27
52 weeks $0.86 $2.32

Historical ContraVir Pharmaceuticals Inc prices

Date Open High Low Close Volume
Apr 05, 2016 $649.60 $649.60 $610.40 $632.80 649
Apr 04, 2016 $672.00 $694.40 $616.00 $649.60 1 341
Apr 01, 2016 $660.80 $683.20 $627.20 $649.60 994
Mar 31, 2016 $711.20 $711.20 $672.00 $677.60 1 381
Mar 30, 2016 $756.00 $756.00 $660.80 $716.80 5 014
Mar 29, 2016 $1,114.40 $1,265.60 $929.60 $935.20 14 288
Mar 28, 2016 $890.40 $890.40 $778.40 $834.40 191
Mar 24, 2016 $812.00 $890.40 $800.80 $862.40 140
Mar 23, 2016 $957.60 $1,008.00 $828.80 $828.80 697
Mar 22, 2016 $705.60 $974.40 $705.60 $974.40 1 698
Mar 21, 2016 $655.20 $716.80 $655.20 $711.20 183
Mar 18, 2016 $644.00 $660.80 $621.60 $638.40 83
Mar 17, 2016 $655.20 $683.20 $616.00 $638.40 115
Mar 16, 2016 $586.88 $705.60 $576.80 $632.80 304
Mar 15, 2016 $599.20 $644.00 $560.00 $565.60 114
Mar 14, 2016 $627.20 $711.76 $593.60 $599.20 115
Mar 11, 2016 $686.00 $686.00 $610.40 $638.40 124
Mar 10, 2016 $711.20 $781.20 $616.00 $632.80 194
Mar 09, 2016 $728.00 $778.40 $711.20 $711.20 148
Mar 08, 2016 $677.60 $784.00 $677.60 $722.40 414
Mar 07, 2016 $548.24 $722.40 $548.24 $677.60 764
Mar 04, 2016 $615.44 $616.00 $532.00 $537.60 162
Mar 03, 2016 $532.00 $638.40 $532.00 $576.80 344
Mar 02, 2016 $509.60 $532.00 $504.00 $526.40 72
Mar 01, 2016 $504.00 $530.88 $504.00 $504.00 25
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT